This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of other and unspecified sites
CD2_INSITU_OTHER_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ locis aliis sive non specificatis
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- In situ neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1176 | 236 | 940 |
| Unadjusted period prevalence (%) | 0.35 | 0.08 | 0.41 |
| Median age at first event (years) | 71.36 | 68.13 | 72.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1088
- Matched controls
- 10878
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
2297.9
323.0
500
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
1013.3
323.0
698
19
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
6889.6
323.0
439
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
323.0
311
*
UKC02
NOMESCO Finland
Cystoscopy
115.5
323.0
1023
1303
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
323.0
672
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
528.1
323.0
589
24
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
323.0
711
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
156.5
297.6
305
27
R31
ICD-10 Finland
Unspecified haematuria
14.9
296.9
579
772
C61
ICD-10 Finland
Malignant neoplasm of prostate
336.6
197.1
194
7
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2269.8
191.4
180
*
ZX136
NOMESCO Finland
Intravesicalis
196.9
177.7
181
11
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
190.4
172.3
176
11
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
+∞
141.8
133
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
50.7
126.9
153
35
WX320
NOMESCO Finland
Spinalanesthesy
4.8
112.4
493
1597
130
Kela drug reimbursment
Malignant tumour
+∞
111.4
105
*
XKD00
NOMESCO Finland
Uroflowmetry
4.7
106.9
468
1495
116
Kela drug reimbursment
Prostate cancer
+∞
92.0
87
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
92.0
87
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.6
89.5
386
1172
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
+∞
87.7
83
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.0
84.0
432
1528
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
+∞
82.3
78
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.3
77.1
200
325
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
71.6
75.6
86
13
TKC20
NOMESCO Finland
Catheterisation of bladder
6.0
73.8
225
453
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
69.5
66
*
KCW96
NOMESCO Finland
Other operations on bladder
65.3
68.5
79
13
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
33.6
64.1
84
27
U06
ICPC
Haematuria
11.2
62.4
122
121
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
325.2
61.0
61
*
L02AE02
ATC
leuprorelin; implant, parenteral
218.8
60.7
62
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
66.8
60.1
69
11
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
59.9
57
*
WF002
NOMESCO Finland
Radical radiotherapy
319.4
59.9
60
*
JN4AD
NOMESCO Finland
Body CT examination
8.0
57.2
136
190
WX402
NOMESCO Finland
General anaesthesia
4.3
56.3
236
657
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
54.6
52
*
A04AA02
ATC
granisetron; systemic, transdermal
192.7
53.4
55
*
JN4BD
NOMESCO Finland
Extensive body CT
6.2
52.4
150
272
H02AB02
ATC
dexamethasone; systemic
21.2
51.7
77
39
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
185.4
51.4
53
*
ZXC20
NOMESCO Finland
Use of chemical agents
20.1
50.8
77
41
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
50.4
48
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
49.3
47
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
488.0
47.7
47
*
WX224
NOMESCO Finland
Blockade of obturius nerve
+∞
47.2
45
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.4
46.7
187
491
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
46.5
260
910
J01MA02
ATC
ciprofloxacin; systemic
2.5
45.6
548
3112
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
466.2
45.6
45
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
44.4
345
1514
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
43.0
41
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.5
42.9
228
763
UKB02
NOMESCO Finland
Retrograde ureteroscopy
16.7
42.7
69
44
L02BB03
ATC
bicalutamide; oral
+∞
41.9
40
*
KCC10
NOMESCO Finland
Cystoprostatectomy
422.7
41.4
41
*
Y77
ICPC
Malignant neoplasm prostate
+∞
40.9
39
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
411.9
40.4
40
*
ZXE00
NOMESCO Finland
One hour or less
2.4
40.0
481
2671
KH1AD
NOMESCO Finland
CT of urinary organs
7.0
38.9
100
155
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
11.1
38.8
75
72
ZXC15
NOMESCO Finland
Use of photodynamic technique
23.1
38.2
55
25
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
15.0
38.1
64
45
4CX01
NOMESCO Finland
NA
+∞
37.7
36
*
N30.0
ICD-10 Finland
Acute cystitis
3.6
37.1
186
589
KCB00
NOMESCO Finland
Biopsy of bladder
80.9
35.0
39
5
XX3DW
NOMESCO Finland
Time consuming IT work
5.2
34.6
113
237
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
34.6
33
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
347.4
34.1
34
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
33.5
32
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
175.2
32.9
34
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
32.4
31
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
31.4
30
*
R33
ICD-10 Finland
Retention of urine
3.2
31.3
184
652
WZC30
NOMESCO Finland
Teaching
3.4
31.2
167
553
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.3
30.5
58
54
U76
ICPC
Malignant neoplasm of bladder
+∞
30.3
29
*
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
+∞
30.3
29
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
30.2
209
824
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.6
30.1
91
174
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
310.5
29.9
30
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.5
29.7
66
82
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
106.2
28.8
31
*
KC1GB
NOMESCO Finland
Cystography with X-ray
65.8
28.1
32
5
KED22
NOMESCO Finland
Transurethral resection of prostate
3.1
27.1
168
614
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.4
26.9
83
163
G04BD12
ATC
mirabegron; oral
2.9
26.8
178
681
JN4CD
NOMESCO Finland
Very extensive body CT
7.1
26.8
67
100
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
26.4
420
2520
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
26.1
25
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
26.1
25
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
9.4
26.0
54
60
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
24.8
25.8
36
15
J01MA12
ATC
levofloxacin; systemic
2.4
25.7
258
1246
Z51.5
ICD-10 Finland
Palliative care
6.2
25.6
71
122
115
Kela drug reimbursment
Breast cancer
+∞
25.1
24
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
25.1
24
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
92.2
24.7
27
*
J01EA01
ATC
trimethoprim; systemic
2.4
24.7
241
1144
ZX090
NOMESCO Finland
Other technic of radiotherapy
133.0
24.7
26
*
G04CA02
ATC
tamsulosin; oral
2.0
24.1
470
3022
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.2
23.7
58
84
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
23.0
22
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
23.0
22
*
WF004
NOMESCO Finland
Palliative radiotherapy
234.6
22.7
23
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
22.5
911
7626
NK6AN
NOMESCO Finland
Total body bone isotope imaging
53.2
22.2
26
5
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
21.9
21
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
21.9
527
3620
KH1DD
NOMESCO Finland
CT urography of urinary organs
81.8
21.7
24
*
A04AA01
ATC
ondansetron; systemic, rectal
8.3
21.6
48
60
KDV10
NOMESCO Finland
Internal urethrotomy
7.5
21.5
51
71
B01AB10
ATC
tinzaparin; parenteral
4.4
21.4
79
188
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
20.9
20
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
42.5
20.5
25
6
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
9.4
20.0
41
45
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
19.8
19
*
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
+∞
19.8
19
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
19.8
19
*
B02AA02
ATC
tranexamic acid; systemic
3.1
19.8
116
403
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
46.9
19.2
23
5
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
19.2
412
2683
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.5
18.8
41
50
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
18.8
18
*
L01BC06
ATC
capecitabine; oral
+∞
18.8
18
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
18.8
18
*
B01AB05
ATC
enoxaparin; parenteral
2.0
18.7
319
1907
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
18.6
110
385
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
101.8
18.6
20
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
193.1
18.6
19
*
A98
ICPC
Health maint/preventive medicine
2.4
18.1
990
8794
KCD30
NOMESCO Finland
Destruction of tumour of bladder
+∞
17.7
17
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
17.7
17
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
96.6
17.6
19
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
96.6
17.6
19
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
17.5
137
573
J01DB01
ATC
cefalexin; oral
1.8
17.3
824
6832
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.9
17.1
72
195
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.7
16.9
75
212
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
16.7
16
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
16.7
16
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
16.7
16
*
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
16.7
16
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
172.4
16.5
17
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.3
16.4
162
763
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.6
16.2
57
130
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
7.8
16.2
37
49
L02BG04
ATC
letrozole; oral
48.2
16.1
19
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
48.2
16.1
19
*
KDE20
NOMESCO Finland
Removal of foreign body from urethra
18.8
16.0
24
13
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
+∞
15.7
15
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
15.7
15
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
162.1
15.5
16
*
ZXC96
NOMESCO Finland
Robot assisted procedure
16.7
14.8
23
14
SPAT1167
SPAT
Insertion of urinary catheter
3.5
14.8
70
210
SPAT1262
SPAT
Handing over of treatment supplies
1.9
14.7
243
1418
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
14.6
14
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
14.6
14
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
14.6
14
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
14.6
14
*
D09.1
ICD-10 Finland
Carcinoma in situ: Other and unspecified urinary organs
+∞
14.6
14
*
SPAT1263
SPAT
Sampling
1.7
14.5
446
3170
KBH20
NOMESCO Finland
Replantation of ureter
151.9
14.5
15
*
L03AA13
ATC
pegfilgrastim; parenteral
151.9
14.5
15
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
151.9
14.5
15
*
KA3EB
NOMESCO Finland
Antegrade pyelography
36.5
14.5
18
5
A02BC02
ATC
pantoprazole; systemic
1.7
14.2
661
5261
WX110
NOMESCO Finland
Local anesthesy
1.6
14.2
620
4848
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
13.9
96
372
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
54.0
13.8
16
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.5
13.7
48
110
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
76.1
13.6
15
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
13.6
13
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
13.6
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.6
13
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
13.6
13
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
141.6
13.5
14
*
D09.9
ICD-10 Finland
Carcinoma in situ, unspecified
141.6
13.5
14
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
141.6
13.5
14
*
N30.9
ICD-10 Finland
Cystitis, unspecified
3.5
13.5
62
182
Z3231
NOMESCO Finland
Registered nurse
1.8
13.1
289
1848
SPAT1153
SPAT
Removal of sutures
1.7
13.1
345
2331
L03AA02
ATC
filgrastim; parenteral
50.6
12.9
15
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
12.5
113
508
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
12.5
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.5
12
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
12.5
12
*
S18
ICPC
Laceration/cut
1.6
12.4
446
3272
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
12.3
226
1358
KBV10
NOMESCO Finland
Removal of stent from ureter
11.2
12.1
22
20
G04CA01
ATC
alfuzosin; oral
1.8
11.9
221
1334
G04BE03
ATC
sildenafil; oral
11.9
11.8
21
18
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
11.5
11
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
11.5
11
*
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
11.5
11
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
11.5
11
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
11.5
11
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
11.5
11
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
11.5
11
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
121.2
11.4
12
*
KBD00
NOMESCO Finland
Partial excision of ureter
121.2
11.4
12
*
KA1FN
NOMESCO Finland
Isotope renography
15.2
11.3
18
12
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
11.2
450
3365
TJF80
NOMESCO Finland
Ostomy education
17.2
11.2
17
10
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.0
11.1
63
215
TKC22
NOMESCO Finland
Catheterisation instruction
4.1
11.1
42
105
SPAT1125
SPAT
Stoma care and guidance
7.2
11.1
26
37
WW500
NOMESCO Finland
Blood transfusion
4.3
10.8
39
93
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
21.7
10.7
15
7
N02AA05
ATC
oxycodone; systemic
2.0
10.5
133
696
XJH00
NOMESCO Finland
Transanal ultrasonography
2.2
10.5
107
510
U29
ICPC
Urinary symptom/complaint other
3.9
10.5
42
111
L02BA01
ATC
tamoxifen; oral
111.0
10.4
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
111.0
10.4
11
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
10.4
10
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
10.4
10
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
10.4
10
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
10.4
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.4
10
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
10.4
10
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
10.4
10
*
R39.1
ICD-10 Finland
Other difficulties with micturition
3.0
10.4
59
202
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.2
10.4
16
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
10.1
130
685
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.9
259
1721
SPAT1312
SPAT
General health counselling
1.6
9.8
313
2197
U07
ICPC
Urine symptom/complaint other
2.5
9.7
76
319
L57.0
ICD-10 Finland
Actinic keratosis
2.2
9.7
101
487
G03HA01
ATC
cyproterone; systemic
55.5
9.7
11
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
9.6
77
324
ZXC50
NOMESCO Finland
Cryotherapy
4.1
9.6
36
90
ZX120
NOMESCO Finland
Intravenous
2.3
9.6
88
399
U05
ICPC
Urination problems other
2.6
9.4
68
273
A04AD12
ATC
aprepitant; systemic
100.8
9.4
10
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
100.8
9.4
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
17.7
9.4
14
8
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
9.4
54
188
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
9.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
+∞
9.4
9
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
9.4
9
*
L02BX03
ATC
abiraterone; oral
+∞
9.4
9
*
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
+∞
9.4
9
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
9.4
9
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
9.4
9
*
L02BX02
ATC
degarelix; parenteral
+∞
9.4
9
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
9.4
9
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
9.4
9
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
9.4
9
*
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
9.3
392
2928
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
10.8
9.3
17
16
J01CA08
ATC
pivmecillinam; oral
1.7
9.3
206
1306
G04BD08
ATC
solifenacin; oral
2.2
9.1
88
412
KBV00
NOMESCO Finland
Insertion of stent into ureter
10.1
9.0
17
17
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
37.0
9.0
11
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.8
8.6
27
57
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
16.4
8.6
13
8
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
8.5
421
3245
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.7
8.5
23
41
ZX112
NOMESCO Finland
Subcutaneous
7.9
8.4
18
23
D09.7
ICD-10 Finland
Carcinoma in situ of other specified sites
+∞
8.3
8
*
7323
FHL
Electrosection of TU bladder wall change
+∞
8.3
8
*
L02BB04
ATC
enzalutamide; oral
+∞
8.3
8
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
8.3
8
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
8.3
8
*
L02AE04
ATC
triptorelin; parenteral
+∞
8.3
8
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
8.3
8
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
8.3
8
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
8.3
8
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
8.3
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.3
8
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
8.2
108
576
GD1AD
NOMESCO Finland
Thorax CT examination
2.8
8.1
51
187
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
8.1
38
116
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
8.1
141
828
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.2
8.0
29
71
R50.9
ICD-10 Finland
Fever, unspecified
1.9
7.8
123
698
A79
ICPC
Malignancy NOS
45.3
7.7
9
*
U01
ICPC
Dysuria/painful urination
2.6
7.7
56
226
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.8
7.7
24
51
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
11.9
7.6
13
11
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
25.2
7.6
10
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.5
7.5
21
39
WX702
NOMESCO Finland
Supraglottic ventilation device
2.6
7.5
52
205
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
80.6
7.4
8
*
TKC00
NOMESCO Finland
Needle biopsy of bladder
80.6
7.4
8
*
KBB00
NOMESCO Finland
Biopsy of ureter
80.6
7.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
80.6
7.4
8
*
KGH10
NOMESCO Finland
Operation for phimosis
2.9
7.4
42
146
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
7.3
32
93
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
7.3
7
*
L01CA04
ATC
vinorelbine; systemic
+∞
7.3
7
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.3
7
*
UJF32
NOMESCO Finland
Coloscopy
1.5
7.2
246
1734
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
7.2
81
404
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
20.2
7.1
10
5
UKD02
NOMESCO Finland
Urethroscopy
7.0
7.0
16
23
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
3.8
7.0
28
76
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
5.0
7.0
21
43
U02
ICPC
Urinary frequency/urgency
1.9
6.9
107
604
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
13.9
6.9
11
8
KE1BG
NOMESCO Finland
MRI of prostate
13.9
6.9
11
8
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
6.9
79
397
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.9
351
2697
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.8
195
1316
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
6.7
48
194
KEB00
NOMESCO Finland
Biopsy of prostate
7.2
6.7
15
21
N21.0
ICD-10 Finland
Calculus in bladder
4.0
6.7
25
64
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.7
465
3774
Z2221
NOMESCO Finland
Medical doctor
1.5
6.7
239
1700
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
6.7
156
1000
XQ848
NOMESCO Finland
Dermatological photography
3.4
6.7
30
90
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
6.7
328
2496
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
6.6
44
171
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.6
453
3666
A06AH03
ATC
naloxegol; oral
12.3
6.6
11
9
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.5
6.5
47
191
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
6.5
83
436
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
5.1
6.5
19
38
HA1AA
NOMESCO Finland
X-ray mammography
4.0
6.5
24
61
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
6.5
160
1042
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
6.4
132
817
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
70.2
6.4
7
*
U13
ICPC
Bladder symptom/complaint other
3.1
6.4
32
104
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.7
6.4
26
72
SPAT1301
SPAT
No procedures
1.4
6.3
323
2470
ZZR00
NOMESCO Finland
Flap of skin
6.0
6.3
16
27
WX882
NOMESCO Finland
High dependency care
3.0
6.3
34
117
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
6.3
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.3
6
*
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
KCC00
NOMESCO Finland
Cystectomy
+∞
6.3
6
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.3
6
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
6.3
6
*
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
6.2
82
437
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.1
299
2270
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
8.6
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
561
638
15.90
307.65
1.9
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
875
413
79.87
307.65
7.4
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
815
2554
8.14
274.03
3.2
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
768
2620
6.57
223.45
6.0
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
629
2024
5.53
188.47
6.6
2.4
e6/l
3.7
3.7
0.02
586
1760
(3002582) Erythrocytes [#/volume] in Urine
736
2883
5.15
168.11
11.1
3.1
e6/l
504.9
108.6
1.60
676
2246
(3030467) Casts [#/volume] in Urine by Automated count
676
2629
4.70
151.72
10.3
3.0
e6/l
0.2
0.5
5.98
594
1996
(3018095) Leukocytes [#/volume] in Urine
759
3276
4.71
146.70
12.2
3.5
e6/l
160.0
98.6
0.99
703
2390
(3031040) Bacteria [#/volume] in Urine by Automated count
1046
5940
7.88
139.23
14.4
4.2
e6/l
52.4
1891.4
1.21
26
104
(36304419) Bacteria [Presence] in Urine
630
2509
4.25
132.38
10.1
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
515
1876
4.10
120.49
7.2
2.6
mosm/kgh2o
585.5
565.7
1.52
476
1563
(4035726)
181
274
7.63
117.33
1.4
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1035
6296
6.37
113.50
10.0
4.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
784
3929
3.99
112.01
5.9
3.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
422
1490
3.86
100.35
10.4
2.9
e6/l
1.1
1.4
0.56
348
849
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
441
1617
3.76
98.92
9.4
2.7
e6/l
1.0
1.0
0.03
366
966
(3044640) Blood type and Crossmatch panel - Blood
565
2569
3.31
87.89
3.2
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
743
4409
2.86
65.03
6.4
3.5
estimate
0.0
0.0
0.00
201
781
(3021601) Nitrite [Presence] in Urine by Test strip
741
4392
2.86
64.98
8.3
4.7
estimate
0.0
0.0
0.00
201
786
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
189
507
4.25
63.90
3.7
1.4
ug/l
24.9
3.7
0.92
157
383
(3030981) Hyaline casts [#/volume] in Urine by Automated count
197
546
4.13
63.72
8.5
2.6
e6/l
0.2
0.3
1.13
197
537
(3009261) Glucose [Presence] in Urine by Test strip
744
4473
2.81
62.50
6.4
3.5
estimate
0.0
0.0
0.00
192
750
(3013826) Glucose [Moles/volume] in Serum or Plasma
867
5683
3.00
61.02
5.8
4.7
mmol/l
6.9
7.0
0.63
843
5314
(3023368) Bacteria identified in Blood by Culture
533
2892
2.54
52.31
5.1
4.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
707
4490
2.44
47.56
7.3
4.0
umol/l
10.7
13.2
12.77
678
4211
(40761535) Cells panel - Urine sediment
235
881
3.08
46.87
6.6
3.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
678
4305
2.36
44.48
12.7
11.8
inr
1.3
1.4
2.00
212
1202
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
396
1996
2.48
43.97
3.2
2.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
931
6918
2.66
41.30
9.4
5.4
u/l
79.6
78.3
0.38
884
6358
(3041096) Erythrocytes [Presence] in Urine by Automated
423
2259
2.36
40.69
6.1
3.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
611
3957
2.13
35.09
6.0
3.8
g/l
34.1
35.0
3.30
570
3614
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1079
8916
3.55
34.56
24.2
14.8
mg/l
31.4
26.9
3.70
941
7078
(40768800) Prostate Pathology biopsy report
61
106
6.01
33.92
1.2
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
690
4722
2.12
33.75
8.0
5.7
mmol/l
1.2
1.2
0.61
577
3961
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1037
8440
2.93
32.92
26.0
13.8
ml/min/173m2
70.7
73.7
4.85
948
6824
(3013650) Neutrophils [#/volume] in Blood by Automated count
688
4777
2.06
31.44
9.7
6.0
e9/l
4.7
4.5
0.67
598
4120
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
538
3433
2.05
30.91
7.2
3.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
381
2150
2.14
30.36
4.9
3.7
%
84.0
80.6
1.68
375
2090
(40761536) Microorganisms panel - Urine sediment
176
730
2.66
28.20
6.1
3.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
373
2151
2.08
27.61
1.4
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1112
9625
3.85
27.54
29.9
18.3
mmol/l
139.5
139.8
2.77
1093
9348
(3023103) Potassium [Moles/volume] in Serum or Plasma
1112
9645
3.81
27.02
30.3
18.4
mmol/l
4.0
4.0
0.53
1092
9355
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
788
5921
2.00
26.80
5.9
4.1
ug/l
2.7
2.8
0.05
704
5271
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
621
4327
1.92
26.19
7.1
5.4
mmol/l
1.2
1.2
0.54
558
3819
(3014576) Chloride [Moles/volume] in Serum or Plasma
255
1293
2.24
26.09
7.5
6.3
mmol/l
105.2
104.3
2.31
250
1252
(40761511) CBC panel - Blood by Automated count
1075
9218
2.94
25.18
24.2
14.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
214
1023
2.33
25.10
5.0
3.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
41
8.00
23.49
1.5
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
579
4042
1.85
23.30
6.5
5.8
%
9.0
9.0
0.16
538
3732
(3006504) Eosinophils/100 leukocytes in Blood
577
4024
1.85
23.30
6.2
5.5
%
2.8
3.0
1.64
538
3700
(3007461) Platelets [#/volume] in Blood
1117
9864
3.64
23.24
36.8
21.5
e9/l
237.9
231.7
2.51
1090
9522
(3035941) MCH [Entitic mass]
1117
9865
3.64
23.21
36.6
21.4
pg
30.4
30.6
4.06
1101
9650
(3024731) MCV [Entitic volume]
1117
9865
3.64
23.21
36.7
21.5
fl
91.8
91.9
0.13
1101
9648
(3010813) Leukocytes [#/volume] in Blood
1117
9866
3.63
23.19
36.9
21.6
e9/l
7.3
6.9
7.74
1088
9476
(3026361) Erythrocytes [#/volume] in Blood
1117
9866
3.63
23.19
36.9
21.5
e12/l
4.4
4.5
6.28
1088
9474
(3002030) Lymphocytes/100 leukocytes in Blood
585
4102
1.85
23.17
6.4
5.6
%
24.2
25.8
2.70
544
3759
(3000963) Hemoglobin [Mass/volume] in Blood
1117
9868
3.63
23.14
37.1
21.7
g/l
132.5
137.1
16.44
1101
9649
(3022096) Basophils/100 leukocytes in Blood
561
3902
1.84
22.63
6.2
5.5
%
0.6
0.7
3.18
524
3595
(42870588) Differential panel, method unspecified - Blood
455
2968
1.87
22.54
5.3
5.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
401
2514
1.90
22.46
7.1
3.8
estimate
0.0
0.0
0.50
179
729
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
301
1713
2.02
22.40
2.0
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
575
4064
1.81
21.70
6.1
5.5
%
60.1
58.7
1.91
541
3752
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
437
2846
1.85
21.53
3.2
2.3
u/l
54.4
58.5
1.67
410
2595
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
66
181
3.80
21.18
4.2
1.8
u/ml
73.8
44.0
0.23
57
142
(3013707) Erythrocyte sedimentation rate by Westergren method
844
6744
1.89
20.86
4.4
4.1
mm/h
16.1
12.8
5.63
751
6142
(3013512) EKG study
462
3098
1.81
20.43
5.1
4.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
158
730
2.35
19.80
4.6
3.4
kpa
5.1
5.1
0.22
149
668
(3009343) pH of Capillary blood
156
718
2.35
19.71
4.7
3.5
ph
7.4
7.4
0.29
18
91
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1084
9564
2.71
19.68
13.1
9.5
u/l
25.4
26.5
1.04
1042
9095
(3013115) Eosinophils [#/volume] in Blood
612
4491
1.76
19.59
5.9
5.3
e9/l
0.2
0.2
0.85
533
3903
(3044889) 12 lead EKG panel
831
6673
1.84
19.41
5.2
4.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
151
691
2.36
19.32
4.4
3.4
mmol/l
1.1
1.8
1.45
118
487
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
156
727
2.32
19.14
1.9
2.0
g/l
0.2
0.2
2.55
142
647
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
570
4127
1.74
18.90
2.5
2.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
593
4360
1.73
18.44
5.8
5.2
e9/l
0.0
0.0
1.20
507
3736
(3001604) Monocytes [#/volume] in Blood
585
4326
1.70
17.48
5.8
5.2
e9/l
0.7
0.6
1.68
499
3696
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
388
2564
1.77
17.41
2.5
2.2
mg/l
3.2
3.0
0.80
328
2152
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
138
636
2.33
17.32
1.9
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
594
4418
1.70
17.31
5.9
5.3
e9/l
1.9
1.8
0.42
523
3828
(3015377) Calcium [Moles/volume] in Serum or Plasma
421
2854
1.74
17.23
4.0
2.0
mmol/l
2.3
2.3
0.07
352
2325
(3009542) Hematocrit [Volume Fraction] of Blood
912
7657
1.85
16.98
25.5
16.4
%
39.0
39.5
0.60
523
4610
(3011397) Hemoglobin [Presence] in Urine by Test strip
340
2178
1.79
16.88
6.0
3.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
118
516
2.43
16.65
4.8
3.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
525
3822
1.67
16.25
14.3
9.1
e9/l
0.0
0.0
0.04
438
3136
(3045414) Leukocytes [Presence] in Urine
93
371
2.64
15.89
3.5
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
397
2706
1.71
15.60
4.5
3.3
ph
7.4
7.4
0.01
90
493
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
89
356
2.62
15.13
4.2
2.9
u/ml
0.3
0.3
0.30
53
205
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
231
1361
1.87
14.85
3.1
2.6
%
18.4
22.8
5.68
195
1148
(3004789) Transferrin [Mass/volume] in Serum or Plasma
241
1442
1.84
14.75
3.0
2.5
g/l
2.3
2.2
1.31
217
1329
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
62
207
3.11
14.69
1.5
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
40
102
4.02
14.23
2.1
1.7
u/ml
419.6
56.4
0.45
35
93
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
88
366
2.52
13.81
3.5
3.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
173
953
1.96
13.56
6.9
6.8
mmol/l
10.8
11.6
0.76
163
895
(3002385) Erythrocyte distribution width [Ratio]
843
7098
1.66
13.45
31.3
17.7
%
14.0
13.8
6.18
829
6905
(3012095) Magnesium [Moles/volume] in Serum or Plasma
230
1396
1.81
13.31
3.9
2.7
mmol/l
0.8
0.8
0.58
214
1281
(3001122) Ferritin [Mass/volume] in Serum or Plasma
468
3458
1.59
12.72
3.3
2.8
ug/l
162.1
164.4
0.07
411
3126
(3035637) Corticotropin [Mass/volume] in Plasma
28
59
4.84
12.64
1.5
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
227
1396
1.78
12.51
2.0
2.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
184
1064
1.86
12.40
3.3
2.6
u/l
221.9
239.9
2.74
174
990
(3003458) Phosphate [Moles/volume] in Serum or Plasma
211
1274
1.80
12.36
6.6
5.4
mmol/l
1.0
1.0
0.15
198
1172
(3022948) Iron [Moles/volume] in Serum or Plasma
249
1578
1.73
12.34
3.1
2.5
umol/l
10.8
12.6
3.48
229
1440
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
90
402
2.34
12.09
2.1
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
928
8099
1.69
11.96
4.8
4.2
mu/l
2.0
2.0
1.25
796
7184
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
606
4795
1.54
11.91
5.2
3.9
%
20.7
24.1
7.46
347
2435
(3000330) Specific gravity of Urine by Test strip
108
524
2.17
11.90
8.2
3.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
158
890
1.90
11.51
2.7
2.4
umol/l
8.6
10.2
0.26
143
776
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
442
3292
1.55
11.25
3.5
2.8
ug/l
0.7
0.8
0.21
335
2340
(3022145) Colonoscopy Study observation
151
845
1.90
11.22
1.4
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
114
579
2.07
11.16
5.6
7.1
mmol/l
24.1
24.8
1.14
114
574
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1011
9087
1.80
11.09
5.7
5.2
mmol/l
6.3
6.2
1.42
876
8098
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
36
102
3.61
11.08
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
152
858
1.89
10.99
8.4
7.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
20
7.58
10.57
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
122
648
1.98
10.55
4.3
2.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
194
1195
1.75
10.51
1.8
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
649
5295
1.50
10.49
3.2
3.0
u/l
58.0
54.9
0.30
592
4773
(3014051) Protein [Presence] in Urine by Test strip
56
214
2.70
10.45
4.8
2.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
38
117
3.32
10.33
3.7
2.8
%
0.7
1.5
0.78
25
80
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
91
438
2.17
10.24
2.4
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
14
18
7.86
10.15
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
166
993
1.78
9.92
5.7
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
119
641
1.95
9.88
4.5
3.7
%
2.5
0.7
0.33
35
132
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
191
1194
1.72
9.78
1.7
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
126
698
1.90
9.63
2.6
2.1
u/l
31.5
39.6
0.60
110
575
(3017181) Myelocytes/100 leukocytes in Blood
127
713
1.88
9.31
4.7
3.5
%
0.9
0.8
0.12
42
176
(3021960) Folate [Moles/volume] in Serum or Plasma
352
2580
1.52
9.26
1.6
1.6
nmol/l
19.2
19.7
0.25
289
2145
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
134
768
1.84
9.21
4.5
3.1
mmol/l
1.2
1.2
0.62
112
656
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
750
6394
1.48
9.12
4.0
3.3
pmol/l
15.1
15.0
0.10
631
5632
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
120
666
1.89
9.11
8.3
8.5
%
1.2
1.4
0.87
120
660
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
119
659
1.90
9.10
8.4
8.6
%
0.5
0.7
4.10
119
652
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
105
558
1.97
9.07
8.5
9.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
122
683
1.88
9.02
4.5
3.6
%
0.2
0.1
0.48
41
159
(3021901) Oxygen saturation in Capillary blood
55
227
2.49
8.83
2.9
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
451
3514
1.46
8.63
3.3
3.2
ng/l
2431.6
1769.1
0.97
400
3028
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
132
2.94
8.49
1.3
1.3
u/l
9.1
7.1
0.63
30
111
(3042631) Mycobacterium sp identified in Specimen
38
133
2.92
8.38
2.7
2.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
30
91
3.36
8.38
1.7
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
989
9013
1.61
8.14
5.1
5.0
mmol/l
4.2
4.3
1.70
860
8207
(3012501) Base excess in Blood by calculation
54
230
2.41
8.12
3.6
4.8
mmol/l
2.5
2.8
0.24
31
149
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
241
1671
1.56
8.04
3.9
2.1
mmol/l
2.5
2.4
3.65
214
1422
(40768441) Liver Pathology biopsy report
15
27
5.61
8.03
1.2
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
98
531
1.92
8.01
8.9
8.9
mmol/l
23.6
24.3
1.88
93
492
(3027315) Oxygen [Partial pressure] in Blood
54
232
2.39
7.97
3.6
4.9
kpa
8.2
8.3
0.21
54
227
(3007853) Bacteria identified in Skin by Aerobe culture
175
1126
1.65
7.97
1.9
1.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
436
3417
1.44
7.92
2.1
2.1
nmol/l
79.7
77.5
0.72
362
2931
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
536
4364
1.42
7.86
2.2
2.1
pmol/l
91.6
92.0
0.08
298
2349
(3015235) Bicarbonate [Moles/volume] in Capillary blood
67
318
2.17
7.84
3.7
3.1
mmol/l
24.1
24.9
0.66
59
280
(3002032) Base excess in Venous blood by calculation
166
1059
1.66
7.81
4.3
3.5
mmol/l
1.1
2.0
2.21
126
838
(3002179) Metamyelocytes/100 leukocytes in Blood
113
647
1.83
7.78
4.5
3.5
%
0.9
0.5
0.88
33
127
(1616796) Gas panel - Central venous blood
55
242
2.34
7.71
3.0
4.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
113
649
1.82
7.71
1.6
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
111
635
1.83
7.67
1.6
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1007
9256
1.61
7.55
5.7
5.6
mmol/l
2.4
2.5
2.10
873
8393
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
349
2643
1.46
7.54
3.1
2.7
u/l
46.6
45.8
0.02
322
2489
(3012516) Albumin [Mass/volume] in Urine
446
3537
1.42
7.48
3.4
3.3
mg/l
200.9
171.5
0.07
316
2355
(3022217) INR in Platelet poor plasma by Coagulation assay
235
1647
1.53
7.42
31.0
30.5
inr
1.4
1.5
0.55
42
230
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
966
8804
1.54
7.42
7.7
6.8
mmol/mol
42.1
41.4
1.42
864
8032
(3003396) Base excess in Arterial blood by calculation
188
1260
1.59
7.22
7.1
6.8
mmol/l
0.2
1.2
3.14
152
967
(3027801) Oxygen [Partial pressure] in Arterial blood
188
1262
1.58
7.17
7.1
6.8
kpa
12.0
11.4
1.02
180
1204
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
188
1262
1.58
7.17
7.1
6.8
kpa
5.0
5.1
0.29
181
1204
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
507
4136
1.40
7.13
5.3
4.1
ng/l
44.2
73.7
1.41
434
3211
(3020682) Albumin/Creatinine [Ratio] in Urine
464
3730
1.40
7.11
4.3
4.1
mg/mmol
10.9
7.7
0.62
321
2470
(3009508) Creatinine [Moles/volume] in Urine
447
3573
1.40
7.07
3.3
3.2
mmol/l
7.5
7.9
1.63
351
2956
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
254
1827
1.50
7.07
1.7
1.6
mg/l
1.7
1.3
0.82
200
1412
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
975
8932
1.54
7.02
5.0
4.9
mmol/l
1.3
1.4
4.03
840
8068
(3052851) Hemolysis interference index of Serum or Plasma
58
272
2.19
7.02
4.1
3.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
60
287
2.15
6.92
1.6
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
116
695
1.74
6.87
2.1
2.2
nmol/l
10.2
15.0
9.24
100
589
(3012544) pH of Venous blood
168
1111
1.60
6.82
4.5
3.5
—
7.4
—
0
8
(3036481) Cortisol [Moles/volume] in Serum or Plasma
117
708
1.72
6.69
3.6
1.7
nmol/l
351.0
363.0
0.22
111
630
(3027945) Reticulocytes/100 erythrocytes in Blood
197
1360
1.54
6.62
2.9
2.0
%
1.7
1.7
0.02
177
1184
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
31
111
2.84
6.62
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
83
459
1.87
6.40
2.0
1.7
ug/l
1.2
1.9
0.58
73
401
(40767503) Oxygen content in Capillary blood by calculation
51
236
2.21
6.40
2.6
2.5
%
15.4
16.3
0.69
27
129
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
945
8647
1.47
6.39
4.6
4.4
mmol/l
1.4
1.3
3.48
806
7734
(40768797) Stomach Pathology biopsy report
175
1186
1.56
6.38
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
267
1991
1.44
6.09
8.4
4.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
29
105
2.81
6.08
1.5
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
31
117
2.69
6.02
1.4
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
502
1.77
5.60
4.7
4.0
mmol/l
23.5
24.3
1.56
74
436
(1761482) Bacteria [#/volume] in Urine by Culture
55
281
2.00
5.39
10.4
4.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
340
2712
1.36
5.11
3.1
2.7
umol/l
6845.7
7429.4
0.06
269
2287
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
87
2.80
5.06
5.2
3.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
32
136
2.39
4.93
1.9
1.7
%
88.9
89.9
0.43
32
136
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
273
2118
1.38
4.85
4.4
4.1
ng/l
468.9
487.3
0.03
235
1847
(3023520) Reticulocytes [#/volume] in Blood
148
1030
1.50
4.76
2.4
2.1
e9/l
62.0
67.8
1.20
117
801
(3006184) Hemoglobin [Mass/volume] in Capillary blood
49
252
1.99
4.74
2.3
2.2
g/l
123.5
132.8
1.19
36
190
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
10
21
4.79
4.53
5.4
1.4
nmol/l
87.4
71.8
—
10
21
(40760892) CBC W Ordered Manual Differential panel - Blood
230
1754
1.39
4.52
5.3
4.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
23
87
2.68
4.50
3.1
2.9
%
63.8
58.5
0.34
12
53
(40768443) Skin Pathology biopsy report
61
344
1.82
4.50
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
25
99
2.56
4.48
1.5
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
16
49
3.30
4.48
1.1
1.2
iu/l
24.0
21.2
0.16
11
44
(3000494) Fungus identified in Specimen by Culture
151
1070
1.47
4.44
1.5
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
18
60
3.03
4.41
1.2
1.3
u/l
13.5
11.0
0.40
18
55
(3051611) Lipemic interference index of Serum or Plasma
22
83
2.68
4.34
3.5
3.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
23
89
2.62
4.32
1.1
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
58
327
1.81
4.29
3.2
2.5
g/l
0.4
0.2
0.56
31
115
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
85
534
1.64
4.28
1.6
1.6
g/l
1.7
1.5
1.73
77
447
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
22
86
2.59
4.06
4.7
2.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
57
326
1.79
4.04
2.9
3.2
pmol/l
4.3
4.4
0.37
52
273
(3028308) Erythrocytes [#/volume] in Pleural fluid
27
117
2.34
4.03
1.4
1.6
e6/l
27750.8
81090.1
0.54
17
75
(3051651) Icteric interference index of Serum or Plasma
15
48
3.15
3.93
3.5
3.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
389
3264
1.29
3.90
2.5
2.2
u/l
208.2
258.0
0.41
357
3044
(3017732) Neutrophils [#/volume] in Blood
89
580
1.58
3.88
3.2
3.4
e9/l
4.5
4.2
0.59
61
395
(3035320) C reactive protein [Mass/volume] in Body fluid
16
55
2.94
3.74
2.8
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
37
189
1.99
3.71
1.3
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
36
184
1.99
3.61
2.4
2.2
%
214.9
198.3
0.48
36
174
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
59
354
1.70
3.57
2.2
2.2
ug/min
199.9
96.4
0.37
33
213
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
78
503
1.59
3.57
2.7
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
26
3.87
3.52
2.2
2.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
99
2.35
3.51
1.0
1.4
nmol/l
—
—
—
0
0
(3000492) Spirometry study
100
686
1.50
3.48
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
223
1.87
3.45
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
223
1.87
3.45
1.3
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
25
113
2.24
3.43
1.5
1.8
mu/l
326.8
266.3
0.27
25
104
(4024509)
20
82
2.46
3.39
1.4
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
10
7.03
3.36
1.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
113
806
1.44
3.25
3.3
2.4
ml/min/173m2
57.8
61.8
0.54
49
325
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
19
4.76
3.24
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
258
2098
1.29
3.22
7.8
3.9
kg/l
1.0
1.0
0.10
39
326
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
193
1.89
3.18
1.6
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
287
2373
1.28
3.14
1.8
1.7
pmol/l
428.7
28295392.2
1.92
216
1912
(3012565) Volume of 24 hour Urine
13
44
2.98
3.14
1.5
2.5
ml
1712.9
2084.2
—
7
38
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
246
1.78
3.11
1.2
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
26
125
2.10
3.10
1.5
1.6
e6/l
1539.9
1794.4
0.18
20
88
(3000570) Elastase.pancreatic [Mass/mass] in Stool
39
217
1.82
3.08
1.4
1.5
ug/g
216.4
277.5
1.12
21
135
(3041354) Potassium [Moles/volume] in Venous blood
29
146
2.01
3.07
2.5
2.1
mmol/l
4.2
4.2
0.13
29
146
(3035285) Chloride [Moles/volume] in Venous blood
29
146
2.01
3.07
2.5
2.1
mmol/l
107.7
105.3
1.72
29
146
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
56
2.70
3.06
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
44
256
1.75
3.01
2.5
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
9
6.69
2.87
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
34
186
1.85
2.85
1.1
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
22
103
2.16
2.82
1.7
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
53
333
1.62
2.76
3.9
1.5
ratio
1.1
1.4
—
6
27
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
341
1.61
2.75
3.8
1.5
mg/l
83.9
36.0
1.03
39
274
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
342
1.61
2.72
3.8
1.5
mg/l
56.7
53.3
0.14
39
273
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
92
656
1.44
2.68
1.9
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
270
2256
1.26
2.68
1.9
1.8
nmol/l
1125.4
1151.5
0.17
188
1694
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
141
1.94
2.62
2.6
2.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
89
635
1.43
2.59
1.9
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
272
1.64
2.47
1.2
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
22
3.65
2.36
2.1
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
71
2.27
2.35
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
43
269
1.62
2.32
3.9
2.9
mmol/l
1.6
1.7
0.40
43
262
(4281824)
10
36
2.79
2.20
1.3
1.2
—
—
—
0
0
(4034850)
19
361
0.52
2.19
17.3
12.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
80
2.14
2.19
2.4
1.8
u/field
1.1
1.2
—
8
29
(3038515) Glucose [Moles/volume] in Venous blood
40
250
1.62
2.18
4.0
3.0
mmol/l
7.5
7.6
0.11
40
243
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
19
3.70
2.15
1.3
1.5
%
43.9
29.9
—
7
14
(40757373) Influenza virus identified in Isolate
8
25
3.21
2.09
2.5
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
25
3.21
2.09
5.4
2.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
305
2646
1.21
2.08
3.8
3.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
130
1025
1.30
2.07
1.3
1.3
titre
416.0
461.3
0.16
25
244
(3036782) Glucose [Moles/volume] in Pleural fluid
18
89
2.04
2.06
1.6
1.4
mmol/l
7.3
6.8
0.34
18
82
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
32
2.83
2.00
8.2
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
378
1.48
2.00
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
70
2.16
1.98
2.3
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
84
2.04
1.96
1.1
1.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
5
11
4.56
1.94
1.0
1.2
umol/l
5.5
1.5
—
5
11
(3026480) Teichoate Ab [Titer] in Serum
5
11
4.56
1.94
1.2
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
16
3.76
1.93
1.5
4.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
135
1.79
1.92
1.5
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
78
2.07
1.91
1.3
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
166
1.70
1.88
1.5
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
26
151
1.74
1.88
5.2
7.6
mmol/l
7.4
7.8
0.25
21
121
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
12
4.18
1.82
2.6
2.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
113
891
1.30
1.82
2.6
1.6
g/l
66.0
66.8
0.55
101
798
(3042111) Morphology [Interpretation] in Bone marrow Narrative
26
153
1.72
1.80
1.3
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
35
2.58
1.80
2.2
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
102
1.88
1.77
1.1
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
124
1.79
1.76
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
99
773
1.31
1.72
1.2
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
13
3.86
1.71
2.6
2.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
13
3.86
1.71
1.0
3.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
92
713
1.31
1.69
4.7
3.9
ng/l
107.5
98.3
0.36
76
613
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
49
0.00
1.68
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
104
1.84
1.68
1.4
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
98
769
1.30
1.65
2.6
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
56
2.15
1.61
1.2
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
56
2.15
1.61
1.2
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
60
439
1.39
1.61
2.4
1.7
u/ml
14.7
36.7
—
5
12
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
63
2.08
1.60
1.2
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
159
1328
1.23
1.60
5.0
5.1
%
32.9
32.7
0.11
99
864
(3033799) Differential panel - Peritoneal fluid
7
26
2.70
1.58
1.7
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
760
7210
1.15
1.55
33.2
19.8
g/l
330.8
332.9
7.68
752
7151
(3014271) Vancomycin [Susceptibility]
13
64
2.04
1.54
3.2
2.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
33
2.43
1.54
1.6
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
51
2.17
1.51
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
21
2.87
1.50
1.5
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
20
116
1.74
1.49
1.5
2.3
ml
825.8
631.4
—
8
73
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
137
1137
1.23
1.47
2.9
2.5
ug/l
6.3
8.2
0.69
121
985
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
132
1.68
1.46
1.2
1.1
iu/ml
1.0
16.2
—
5
25
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
28
2.51
1.45
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
22
2.74
1.43
2.2
4.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
141
1.64
1.42
3.5
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
205
1.53
1.41
1.7
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
96
1.78
1.39
1.3
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
53
2.09
1.38
2.2
2.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
41
2.20
1.37
2.7
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
71
549
1.31
1.37
5.3
3.6
%
48.5
47.3
0.15
71
540
(3024471) HLA-A [Type]
6
23
2.62
1.37
1.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
17
2.95
1.36
1.6
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
32
216
1.49
1.34
1.8
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
98
1.75
1.31
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
98
1.75
1.31
1.3
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
14
76
1.85
1.30
1.9
2.3
ph
7.4
7.4
—
6
32
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
35
243
1.45
1.29
1.7
1.6
iu/ml
1.4
11.7
—
9
53
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
48
2.09
1.28
3.1
3.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
227
1.47
1.27
5.5
3.6
mg/l
29.9
30.6
0.04
21
145
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
54
406
1.35
1.27
1.3
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
70
1.87
1.24
1.2
1.3
promille
2.0
1.2
—
8
53
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
131
1.61
1.24
1.7
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
29
196
1.49
1.22
1.7
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
19
2.64
1.21
1.0
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
14
78
1.80
1.21
1.6
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
46
341
1.36
1.19
1.3
1.7
u/l
37.3
38.6
0.20
37
277
(46235355) HIV 1 and 2 tests - Meaningful Use set
98
805
1.24
1.19
1.9
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
38
2.11
1.18
1.5
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
38
2.11
1.18
1.5
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
35
248
1.42
1.18
4.8
3.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
141
1.57
1.17
1.5
1.4
%
61.8
68.8
0.31
13
89
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
94
1.71
1.17
1.3
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
14
79
1.78
1.17
1.4
1.9
min
538.6
494.0
—
5
57
(3019060) Gas panel - Arterial blood
95
781
1.24
1.15
4.8
4.8
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
39
2.06
1.15
1.9
2.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
20
2.51
1.15
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
95
1.69
1.14
1.3
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
17
103
1.66
1.13
1.2
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
151
1.53
1.12
1.9
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
176
1.49
1.11
1.1
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
96
1.68
1.10
2.2
1.2
u/ml
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
96
1.68
1.10
1.3
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
31
2.27
1.10
3.3
2.0
ug/l
44.0
55.5
—
7
31
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
25
168
1.50
1.10
2.7
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
21
2.39
1.09
1.0
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
60
471
1.29
1.08
1.6
1.4
g/l
1.1
1.1
0.11
54
433
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
59
1.87
1.07
1.1
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
46
348
1.33
1.07
5.3
6.1
mmol/l
1.3
1.3
0.41
40
310
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
22
2.28
1.03
3.0
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
138
1.53
1.03
3.8
3.3
%
58.7
59.0
0.02
21
138
(3023419) Bacteria identified in Sputum by Culture
24
163
1.48
1.02
1.6
2.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
55
431
1.29
1.01
4.3
4.1
mmol/l
1.3
1.4
0.28
55
422
(3039443) Prostate specific Ag panel - Serum or Plasma
14
225
0.62
1.00
1.4
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
115
1.57
1.00
3.1
4.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
50
1.81
0.96
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
133
1.51
0.94
1.2
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
51
1.77
0.94
1.4
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
37
1.90
0.94
2.0
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
37
1.90
0.94
2.0
2.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
90
755
1.21
0.93
7.4
6.9
mmol/l
24.3
24.5
0.18
85
704
(3004451) EKG impression Narrative
10
55
1.83
0.92
1.7
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
134
1.50
0.92
3.4
3.1
e9/l
5.3
4.6
0.61
20
134
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
277
2535
1.12
0.91
1.6
1.6
mmol/l
1.4
1.3
1.02
212
2069
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
71
1.70
0.89
1.0
1.0
—
—
—
0
0
(4146454)
21
144
1.47
0.87
2.3
2.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
36
273
1.33
0.86
1.2
1.1
—
8.0
—
0
8
(3000012) Reticulocyte production index
11
64
1.73
0.86
1.1
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
152
1346
1.15
0.84
1.6
1.3
g/l
3.1
3.0
0.17
94
786
(3020876) Protein [Mass/time] in 24 hour Urine
14
88
1.60
0.84
1.9
1.9
—
1.1
—
0
6
(44806420)
8
46
1.74
0.82
2.6
2.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
147
1.44
0.80
1.2
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
33
1.82
0.79
1.0
1.7
u/ml
1628.8
987.5
—
6
33
(3000285) Sodium [Moles/volume] in Blood
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
48
1.67
0.79
1.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
27
199
1.37
0.78
1.6
1.6
mg/l
10.8
12.3
0.34
21
181
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
131
1.46
0.78
1.7
2.4
mg/l
13.2
19.8
—
5
29
(3027456) Digoxin [Moles/volume] in Serum or Plasma
34
261
1.31
0.77
3.0
3.2
nmol/l
0.8
0.8
0.05
28
206
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
34
1.77
0.76
6.0
5.6
%
13.3
13.4
—
6
34
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
161
0.62
0.75
1.3
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
53
1.70
0.75
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
53
1.70
0.75
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
9
54
1.67
0.74
1.8
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
25
2.00
0.72
1.6
2.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
25
2.00
0.72
2.2
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
255
1.30
0.72
1.5
1.5
—
—
—
0
0
(4015189)
7
40
1.75
0.71
2.3
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
186
1.35
0.70
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
400
1.23
0.70
3.3
1.4
g/l
3.2
3.1
0.33
35
321
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
45
364
1.25
0.70
4.1
1.5
g/l
1.2
0.5
0.76
33
313
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
428
1.22
0.69
3.2
1.4
g/l
3.9
3.9
0.04
35
318
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
428
1.22
0.69
3.2
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
428
1.22
0.69
3.2
1.4
g/l
7.5
7.5
0.07
35
325
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
16
226
0.70
0.67
1.3
1.2
—
40.7
—
0
10
(3017569) Oxygen content in Arterial blood
12
78
1.54
0.65
1.8
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
259
0.73
0.65
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
35
278
1.27
0.64
1.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
32
252
1.28
0.63
1.5
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
26
199
1.31
0.62
1.2
1.2
u/l
49.9
20.5
0.56
26
173
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
409
0.80
0.58
2.0
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
81
1.49
0.57
1.4
2.0
%
10.0
10.6
0.13
12
81
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
115
1.40
0.56
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
73
1.51
0.56
1.1
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
55
1.46
0.56
2.5
2.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
89
0.56
0.56
1.8
2.1
ug/l
1.4
1.8
—
5
76
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
37
1.62
0.55
1.3
3.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
90
1.45
0.55
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
38
314
1.22
0.52
1.3
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
161
1.31
0.52
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
47
398
1.19
0.51
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
9
65
1.39
0.50
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.6
2.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
48
1.46
0.47
1.0
2.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
15
111
1.36
0.46
1.5
1.3
u/ml
98.9
101.7
—
7
15
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
49
1.43
0.46
1.3
1.5
pmol/l
203.9
66.7
—
7
49
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
119
1087
1.11
0.45
3.6
3.1
ng/l
301.5
247.9
0.56
110
1022
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
404
1.17
0.44
3.4
1.4
g/l
10.4
10.8
0.30
36
344
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
166
1.27
0.43
1.2
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
163
1519
1.08
0.42
1.2
1.2
u/ml
2.0
1.7
0.12
32
409
(3022689) Creatine [Moles/volume] in Urine
5
33
1.52
0.41
2.0
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
343
1.17
0.40
1.1
1.2
iu/ml
158.4
127.4
—
9
133
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
66
1.37
0.38
1.6
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
66
1.37
0.38
1.2
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
u/ml
—
24.8
—
0
5
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
115
0.69
0.37
1.4
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
125
1.28
0.37
1.2
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
17
134
1.27
0.37
1.5
1.2
—
23.3
—
0
5
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
16
201
0.79
0.35
1.8
1.3
e6/l
1072.7
818.9
0.09
11
170
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
201
0.79
0.35
1.7
1.3
e6/l
17.3
44.8
—
10
166
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
117
1.29
0.35
1.1
1.2
u/ml
285.5
292.0
—
6
65
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
6
43
1.40
0.35
1.2
1.4
u/l
—
10.8
—
0
18
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
44
1.37
0.34
1.2
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
19
232
0.82
0.34
1.3
1.3
mg/l
754.5
516.7
0.63
19
212
(21494755) Public health laboratory ask at order entry panel
27
318
0.85
0.33
1.4
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
16
199
0.80
0.33
1.3
1.3
mmol/l
4.0
4.0
0.06
16
181
(3000475) Leukocytes [#/volume] in Synovial fluid
33
284
1.17
0.33
1.7
1.6
e6/l
13948.3
16514.2
0.22
23
208
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
177
0.79
0.33
1.3
1.1
—
16.2
—
0
15
(3044290) Cell count panel - Cerebral spinal fluid
14
176
0.79
0.32
1.7
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
154
0.78
0.32
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
53
475
1.12
0.31
5.3
4.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
138
1.24
0.30
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
57
515
1.11
0.30
1.1
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
102
1.28
0.30
1.2
1.4
%
14.7
21.2
—
7
67
(3043409) Potassium [Moles/volume] in Arterial blood
41
363
1.13
0.29
4.9
4.5
mmol/l
4.0
4.0
0.07
34
332
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
85
1.30
0.28
1.1
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
8
66
1.21
0.26
1.0
1.1
nmol/l
—
11.5
—
0
17
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
14
113
1.24
0.26
1.1
1.0
g/l
1.4
1.6
0.85
14
98
(4062490)
10
77
1.30
0.26
1.8
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
75
0.67
0.26
2.0
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
75
0.67
0.26
2.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
75
0.67
0.26
2.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
132
1.22
0.25
1.5
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
36
321
1.13
0.24
4.1
1.4
g/l
0.4
0.0
0.60
31
297
(3051593) INR in Capillary blood by Coagulation assay
9
76
1.19
0.24
2.9
13.6
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
6
82
0.73
0.24
1.3
1.1
—
65.6
—
0
5
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
237
1.14
0.23
1.1
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
12
97
1.24
0.23
1.3
1.2
nmol/l
1.2
1.5
0.59
12
85
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
40
1.25
0.22
2.6
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
27
239
1.13
0.21
1.1
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(44813793)
5
43
1.16
0.21
1.2
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
19
219
0.87
0.20
1.4
1.4
nmol/l
1.2
0.8
1.00
12
178
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
38
345
1.10
0.20
4.0
1.4
g/l
35.8
37.4
0.74
29
293
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
14.5
—
0
14
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
48
1.25
0.20
1.3
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
127
1.18
0.19
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
90
1.22
0.19
1.5
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
299
1.11
0.18
1.1
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
33
299
1.11
0.18
4.4
1.4
g/l
0.0
0.0
0.00
28
276
(3001019) Free T4 and TSH panel - Serum or Plasma
12
143
0.84
0.18
1.4
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
121
1265
0.95
0.18
1.2
1.2
u/ml
5.5
12.6
1.24
32
449
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
61
1.15
0.17
1.1
1.1
mmol/l
2.3
2.0
—
7
56
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
134
1287
1.05
0.17
1.2
1.3
iu/ml
23.0
39.6
1.56
36
382
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
268
0.89
0.17
4.1
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
69
0.72
0.17
1.4
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
235
1.11
0.16
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
57
537
1.06
0.15
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
82
1.10
0.15
1.9
1.2
—
—
—
0
0
(4094501)
24
264
0.91
0.14
1.1
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
10
84
1.19
0.14
1.0
1.4
—
200.0
—
0
9
(4306422)
11
94
1.17
0.13
1.4
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
283
0.92
0.12
1.1
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
127
0.86
0.12
1.0
1.0
—
—
—
0
0
(44790049)
12
104
1.16
0.12
2.1
1.5
—
—
—
0
0
(44806118)
12
104
1.16
0.12
2.1
1.5
—
—
—
0
0
(44790048)
12
104
1.16
0.12
2.1
1.5
—
—
—
0
0
(44790047)
12
104
1.16
0.12
2.1
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
219
0.91
0.11
1.5
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
44
1.14
0.10
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
44
1.14
0.10
1.2
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
44
1.14
0.10
1.8
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
46
1.09
0.09
1.0
1.1
nmol/l
145.0
140.1
—
5
46
(3015171) Extractable nuclear Ab [Units/volume] in Serum
31
292
1.06
0.08
1.3
1.2
—
0.9
—
0
28
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.0
2.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
6
72
0.83
0.07
1.0
1.2
mmol/l
30.3
35.4
—
6
63
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
74
1.08
0.07
1.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
81
0.86
0.07
1.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
81
0.86
0.07
1.0
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
80
0.87
0.07
1.0
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
82
0.85
0.07
2.0
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
85
0.82
0.07
1.7
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
90
0.89
0.06
1.8
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
94
0.85
0.06
1.3
1.2
—
69.1
—
0
5
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
83
811
1.03
0.05
1.2
1.7
%
1.7
1.7
0.24
66
672
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
178
1.07
0.05
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
90
1.11
0.05
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
91
1.10
0.04
1.3
1.2
u/ml
14.0
6.6
—
5
48
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
10
91
1.10
0.04
1.7
1.6
—
2064.0
—
0
5
(21494890) Protein electrophoresis panel - 24 hour Urine
11
102
1.08
0.03
1.5
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
122
1.07
0.02
1.5
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
162
1.05
0.02
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
26
268
0.97
0.02
1.2
1.8
nmol/l
43.0
45.4
0.24
26
249
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
278
0.97
0.02
1.3
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
79
782
1.01
0.01
2.3
2.1
ug/g
171.1
180.7
0.08
58
601
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
94
1.06
0.01
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
104
1.06
0.01
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
184
1.03
0.00
1.8
1.4
—
—
—
0
0
(1002224) Polysomnography panel
23
234
0.98
0.00
1.0
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
23
232
0.99
0.00
2.4
2.8
umol/l
32.4
37.3
0.37
16
199
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
88
882
1.00
0.00
1.5
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
140
1397
1.00
0.00
8.2
7.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
265
1.02
0.00
1.5
1.4
—
—
—
0
0
(4010399)
72
715
1.01
0.00
1.5
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
125
0.96
0.00
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
83
0.96
0.00
2.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
78
0.90
0.00
1.0
1.6
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
394.7
—
0
9
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.0
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
7
79
0.89
0.00
1.0
1.5
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
6
65
0.92
0.00
1.5
1.7
mmol/l
10.7
10.0
—
6
53
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
92
0.98
0.00
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
9.3
—
0
6
(40757494) Bilirubin.total [Moles/volume] in Blood
6
69
0.87
0.00
2.0
1.8
—
21.1
—
0
7
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
51
0.98
0.00
3.8
3.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
190
1.00
0.00
1.4
1.6
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
14.1
—
0
8
(4268621)
6
67
0.89
0.00
2.7
2.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
63
0.95
0.00
1.0
1.3
—
—
—
0
0
(4211845)
5
58
0.86
0.00
3.8
3.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_OTHER_NOS_EXALLC – Carcinoma in situ of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).